Anti-Mullerian hormone (AMH) is a protein hormone that is produced by the ovarian follicles in women. It is an essential marker for assessing ovarian reserve, which is the number and quality of eggs that a woman has left. AMH analysis is a blood test that measures the levels of this hormone in the blood.
During a woman’s reproductive years, the ovarian follicles produce AMH, which reflects the quantity and quality of the eggs in the ovaries. The AMH levels are highest during a woman’s early reproductive years and gradually decline as she ages. AMH levels can also be used to diagnose polycystic ovary syndrome (PCOS), a common endocrine disorder that affects women of reproductive age.
AMH analysis is a simple blood test that can be done at any time during a woman’s menstrual cycle, and the results are usually available within a few days. The test is usually recommended for women who are considering fertility treatments, such as in vitro fertilization (IVF) or egg freezing.
AMH analysis can help to predict a woman’s response to ovarian stimulation during fertility treatments. Women with high AMH levels tend to respond better to ovarian stimulation and produce more eggs, while women with low AMH levels may require higher doses of medication or may not respond as well to ovarian stimulation.
In addition, AMH analysis can be useful for predicting the onset of menopause. As a woman’s ovarian reserve declines, her AMH levels will decrease. A low AMH level can indicate that a woman is approaching menopause or has already entered menopause.
Overall, AMH analysis is a valuable tool for assessing ovarian reserve and predicting a woman’s response to fertility treatments. It is a non-invasive and simple test that can provide important information about a woman’s fertility potential.
